World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
26431
World Ranking
15565
National Ranking
7843

Gary N. Holland publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary N. Holland sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 383 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary N. Holland D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary N. Holland sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary N. Holland is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the field of Medicine, with a strong focus on the subfield of Ophthalmology, complemented by work in Epidemiology, Oncology, Hematology, and Rheumatology.

The scientist's work addresses several specialized topics within ophthalmic and systemic conditions. These include:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Autoimmune and Inflammatory Disorders Research
  • Cancer Immunotherapy and Biomarkers
  • Systemic Lupus Erythematosus Research
  • Cytomegalovirus and herpesvirus research
  • Herpesvirus Infections and Treatments

Gary N. Holland has contributed to multiple research articles published in notable academic journals. Frequent publication venues include:

  • American Journal of Ophthalmology
  • Ophthalmology
  • Ocular Immunology and Inflammation
  • JAMA Ophthalmology
  • Arthritis Care & Research

Recent papers showcase the diversity and scope of their research, such as:

  • "Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic," 2020, Ophthalmology
  • "Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry," 2020, Ophthalmology
  • "Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis," 2021, Arthritis Care & Research
  • "Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment," 2021, American Journal of Ophthalmology
  • "Prospective, Randomized Trial Comparing Simulator-based versus Traditional Teaching of Direct Ophthalmoscopy for Medical Students," 2021, American Journal of Ophthalmology

Throughout their career, Gary N. Holland has frequently collaborated with several researchers, including:

  • Anne L. Coleman
  • Janet Davis Miami
  • Eve J. Higginbotham
  • S Philadelphia
  • Michael Stewart

Best Publications

  • Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

    Russell W Read;Gary N Holland;Narsing A Rao;Khalid F Tabbara

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • Acquired immune deficiency syndrome. Ocular manifestations.

    Gary N. Holland;Gary N. Holland;Jay S. Pepose;Thomas H. Pettit;Thomas H. Pettit;Michael S. Gottlieb

  • Standard Diagnostic Criteria for the Acute Retinal Necrosis Syndrome

    Gary N. Holland

  • Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

    Gary N Holland

  • Causes of Uveitis in the General Practice of Ophthalmology

    Colin A. McCANNEL;Gary N. Holland;Craig J. Helm;Peter J. Cornell

  • Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease.

    Jay S. Pepose;Jay S. Pepose;Gary N. Holland;Gary N. Holland;Mark S. Nestor;Alistair J. Cochran

  • Ocular Infection and Immunity

    Jay S. Pepose;Gary N. Holland;Kirk R. Wilhelmus

  • The tubulointerstitial nephritis and uveitis syndrome.

    John T.H Mandeville;Ralph D Levinson;Gary N Holland

  • Intravenous Cidofovir for Peripheral Cytomegalovirus Retinitis in Patients with AIDS: A Randomized, Controlled Trial

    J P Lalezari;R J Stagg;B D Kuppermann;G N Holland

  • Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

    Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs

  • Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.

    Gary N Holland

  • A Controlled Retrospective Study of Ganciclovir Treatment for Cytomegalovirus Retinopathy: Use of a Standardized System for the Assessment of Disease Outcome

    Gary N. Holland;William C. Buhles;Barbara Mastre;Henry J. Kaplan

  • The Progressive Outer Retinal Necrosis Syndrome: A Variant of Necrotizing Herpetic Retinopathy in Patients with AIDS

    Robert E. Engstrom;Gary N. Holland;Gary N. Holland;Todd P. Margolis;Cristina Muccioli

  • Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome

    Gary N. Holland;Robert E. Engstrom;Ben J. Glasgow;Brian B. Berger

  • The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.

    Craig J. Helm;Gary N. Holland

  • Ocular Disorders Associated with a new Severe Acquired Cellular Immunodeficiency Syndrome

    Gary N. Holland;Michael S. Gottlieb;Robert D. Yee;Howard M. Schanker

  • The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

    Claudio Silveira;Rubens Belfort;Cristina Muccioli;Gary N Holland

  • Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

    David A. Palay;Paul Sternberg;Janet Davis;Hilel Lewis

  • Research Criteria for the Diagnosis of Birdshot Chorioretinopathy: Results of an International Consensus Conference

    Ralph D. Levinson;Antoine Brezin;Aniki Rothova;Massimo Accorinti

Frequent Co-Authors

Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
Rubens Belfort
Rubens Belfort Federal University of Sao Paulo
Mark A. Jacobson
Mark A. Jacobson University of California, San Francisco
Narsing A. Rao
Narsing A. Rao University of Southern California
Jeffrey L. Jones
Jeffrey L. Jones Centers for Disease Control and Prevention
Janet L. Davis
Janet L. Davis University of Miami
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
James T. Rosenbaum
James T. Rosenbaum Oregon Health & Science University
William R. Freeman
William R. Freeman University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and supplementary career pathways in healthcare is a smart strategy for anyone interested in medicine. Online degree programs can provide the flexibility to advance your career without relocating or pausing employment. Popular options include nursing and nurse practitioner programs, many of which are offered fully online.

If you're seeking advanced clinical roles, consider researching the most affordable online nurse practitioner programs to become a leader in patient care. For those starting out, there are many affordable online nursing programs suitable for entry-level and returning students alike.

Aspiring to reach the highest academic position in nursing? Explore online nursing phd programs that open doors to teaching, research, and leadership opportunities. Meanwhile, registered nurses looking to expand their qualifications can benefit from the cheapest rn to bsn online programs to increase career mobility and earning potential.

Online degrees offer a convenient path to advance in the healthcare sector, allowing you to tailor your education to your individual needs and career ambitions.

Best Scientists Citing Gary N. Holland

Trending Scientists

Recently Published Articles